A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
M Singh, MM Kadhim, A Turki Jalil, SK Oudah… - Cancer Cell …, 2023 - Springer
Purpose Although doxorubicin chemotherapy is commonly applied for treating different
malignant tumors, cardiotoxicity induced by this chemotherapeutic agent restricts its clinical …
malignant tumors, cardiotoxicity induced by this chemotherapeutic agent restricts its clinical …
The cardioprotective effects of nano‐curcumin against doxorubicin‐induced cardiotoxicity: A systematic review
H Moutabian, R Ghahramani‐Asl, T Mortezazadeh… - Biofactors, 2022 - Wiley Online Library
Although the chemotherapeutic drug, doxorubicin, is commonly used to treat various
malignant tumors, its clinical use is restricted because of its toxicity especially cardiotoxicity …
malignant tumors, its clinical use is restricted because of its toxicity especially cardiotoxicity …
In vitro and in vivo cardioprotective effects of curcumin against doxorubicin‐induced cardiotoxicity: A systematic review
Q Zhang, L Wu - Journal of oncology, 2022 - Wiley Online Library
Objective. This study aimed to review the potential chemoprotective effects of curcumin
against the doxorubicin‐induced cardiotoxicity. Methods. According to the PRISMA …
against the doxorubicin‐induced cardiotoxicity. Methods. According to the PRISMA …
Cetuximab: its unique place in head and neck cancer treatment
P Specenier, JB Vermorken - Biologics: Targets and Therapy, 2013 - Taylor & Francis
Head and neck cancer is the sixth most common cancer worldwide. At present, globally
about 650,000 new cases of squamous cell carcinoma of the head and neck (SCCHN) are …
about 650,000 new cases of squamous cell carcinoma of the head and neck (SCCHN) are …
A cost‐effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer
DM Graham, W Isaranuwatchai, S Habbous… - Cancer, 2015 - Wiley Online Library
BACKGROUND Many western countries have established female human papillomavirus
(HPV) vaccination programs for the prevention of cervical cancer. The quadrivalent HPV …
(HPV) vaccination programs for the prevention of cervical cancer. The quadrivalent HPV …
A systematic literature review of health state utility values in head and neck cancer
M Meregaglia, J Cairns - Health and quality of life outcomes, 2017 - Springer
Background Health state utility values (HSUVs) are essential parameters in model-based
economic evaluations. This study systematically identifies HSUVs in head and neck cancer …
economic evaluations. This study systematically identifies HSUVs in head and neck cancer …
Toxicity reduction and efficacy promotion of doxorubicin in the treatment of breast tumors assisted by enhanced oral absorption of curcumin-loaded lipid–polyester …
N Wang, Y Zhang, H Liu, A Wang, T Ren… - Molecular …, 2020 - ACS Publications
Curcumin (CUR), a polyphenol derived from turmeric, exhibits anticancer and anti-
inflammatory properties. However, it has poor water solubility, stability, and oral …
inflammatory properties. However, it has poor water solubility, stability, and oral …
A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada
C Beauchemin, N Letarte, K Mathurin… - Journal of medical …, 2016 - Taylor & Francis
Objective Considering the increasing number of treatment options for metastatic breast
cancer (MBC), it is important to develop high-quality methods to assess the cost …
cancer (MBC), it is important to develop high-quality methods to assess the cost …
Cetuximab plus chemotherapy versus chemotherapy alone in recurrent or metastatic head and neck squamous cell carcinoma: a cost-effectiveness analysis
Y Lang, D Dong - Cancer Management and Research, 2020 - Taylor & Francis
Objective The EXTREME clinical trial revealed that cetuximab plus chemotherapy improved
the overall survival time of patients with recurrent or metastatic head and neck squamous …
the overall survival time of patients with recurrent or metastatic head and neck squamous …
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
N van der Linden, J Buter, CP Pescott… - European Archives of …, 2016 - Springer
For patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
(R/M SCCHN), chemotherapy can prolong life and alleviate symptoms. However, expected …
(R/M SCCHN), chemotherapy can prolong life and alleviate symptoms. However, expected …